AbbVie Inc ABBV:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/12/24 EDT
170.30quote price arrow up+0.02 (+0.01%)
Volume
312,628
Close
170.28quote price arrow up+0.37 (+0.22%)
Volume
3,815,818
52 week range
134.12 - 182.89
Loading...
  • Open170.63
  • Day High171.62
  • Day Low169.90
  • Prev Close169.91
  • 52 Week High182.89
  • 52 Week High Date03/12/24
  • 52 Week Low134.12
  • 52 Week Low Date07/14/23

Key Stats

  • Market Cap300.692B
  • Shares Out1.77B
  • 10 Day Average Volume6.58M
  • Dividend6.20
  • Dividend Yield3.64%
  • Beta0.62
  • YTD % Change9.88

KEY STATS

  • Open170.63
  • Day High171.62
  • Day Low169.90
  • Prev Close169.91
  • 52 Week High182.89
  • 52 Week High Date03/12/24
  • 52 Week Low134.12
  • 52 Week Low Date07/14/23
  • Market Cap300.692B
  • Shares Out1.77B
  • 10 Day Average Volume6.58M
  • Dividend6.20
  • Dividend Yield3.64%
  • Beta0.62
  • YTD % Change9.88

RATIOS/PROFITABILITY

  • EPS (TTM)3.36
  • P/E (TTM)50.72
  • Fwd P/E (NTM)14.81
  • EBITDA (TTM)24.772B
  • ROE (TTM)55.92%
  • Revenue (TTM)54.403B
  • Gross Margin (TTM)66.27%
  • Net Margin (TTM)11.04%
  • Debt To Equity (MRQ)924.20%

EVENTS

  • Earnings Date07/25/2024
  • Ex Div Date07/15/2024
  • Div Amount1.55
  • Split Date-
  • Split Factor-

Profile

MORE
AbbVie Inc. is a diversified research-based biopharmaceutical company. The Company is engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in therapeutic categories, including immunology, which include Humira, Skyrizi and Rinvoq; oncology, which include Imbruvica, Venclexta/Venclyxto, Epkinly and Elahere; aesthetics products, which include Botox Cosmetic, The Juvederm Collection of Fillers and...
Richard Gonzalez
Executive Chairman of the Board
Robert Michael CPA
Chief Executive Officer, Director
Scott Reents
Chief Financial Officer, Executive Vice President
Perry Siatis
Executive Vice President, General Counsel, Company Secretary
Nicholas Donoghoe M.D.
Executive Vice President, Chief Business and Strategy Officer
Address
1 N Waukegan Rd
North Chicago, IL
60064
United States

Top Peers

SYMBOLLASTCHG%CHG
MRK
Merck & Co Inc
127.76-1.21-0.94%
AZN
AstraZeneca PLC
79.24+1.30+1.67%
NVS
Novartis AG
111.70+1.20+1.09%
RHHBY
Roche Holding AG
35.69+0.53+1.51%
PFE
Pfizer Inc
28.92+0.26+0.91%